These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2526568)
1. Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor. Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; White D; Oglesby TD; Wasley JW Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():86-9. PubMed ID: 2526568 [TBL] [Abstract][Full Text] [Related]
2. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314 [TBL] [Abstract][Full Text] [Related]
3. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452 [TBL] [Abstract][Full Text] [Related]
4. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate is a potent inhibitor of 5-lipoxygenase. Pergola C; Jazzar B; Rossi A; Buehring U; Luderer S; Dehm F; Northoff H; Sautebin L; Werz O J Pharmacol Exp Ther; 2011 Jul; 338(1):205-13. PubMed ID: 21447614 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. Matera G; Cook JA; Hennigar RA; Tempel GE; Wise WC; Oglesby TD; Halushka PV J Pharmacol Exp Ther; 1988 Oct; 247(1):363-71. PubMed ID: 3171981 [TBL] [Abstract][Full Text] [Related]
6. Reactions of hydroperoxy-eicosatetraenoic acids with arachidonate 12- and 5-lipoxygenases purified from porcine leukocytes. Yamamoto S; Yokoyama C; Ueda N; Shinjo F; Kaneko S; Yoshimoto T Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():17-26. PubMed ID: 2949547 [No Abstract] [Full Text] [Related]
7. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Palmantier R; Surette ME; Sanchez A; Braquet P; Borgeat P Lab Invest; 1994 May; 70(5):696-704. PubMed ID: 8196365 [TBL] [Abstract][Full Text] [Related]
8. Effects of dietary vitamin E on the biosynthesis of 5-lipoxygenase products by rat polymorphonuclear leukocytes (PMNL). Chan AC; Tran K; Pyke DD; Powell WS Biochim Biophys Acta; 1989 Oct; 1005(3):265-9. PubMed ID: 2508746 [TBL] [Abstract][Full Text] [Related]
10. The role of diacylglyceride generation by phospholipase D and phosphatidic acid phosphatase in the activation of 5-lipoxygenase in polymorphonuclear leukocytes. Albert D; Pergola C; Koeberle A; Dodt G; Steinhilber D; Werz O J Leukoc Biol; 2008 Apr; 83(4):1019-27. PubMed ID: 18218859 [TBL] [Abstract][Full Text] [Related]
11. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC; Meier KE; Henderson WR J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073 [TBL] [Abstract][Full Text] [Related]
12. Effects of caffeoylglycosides on arachidonate metabolism in leukocytes. Kimura Y; Okuda H; Nishibe S; Arichi S Planta Med; 1987 Apr; 53(2):148-53. PubMed ID: 3110811 [No Abstract] [Full Text] [Related]
14. [Effect of herba schizonepetae volatile oil (STO) on activity of 5-lipoxygenase in rat thoracic cavity leukocytes]. Zhao L; Zeng N; Tang YX; Liu XS; Yang X; Qu LP Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2154-7. PubMed ID: 19066064 [TBL] [Abstract][Full Text] [Related]
15. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. Rouzer CA; Kargman S J Biol Chem; 1988 Aug; 263(22):10980-8. PubMed ID: 3134355 [TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition. Boctor AM; Burke C; Hovinga ME Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
18. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase. Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286 [TBL] [Abstract][Full Text] [Related]
19. Versatile arachidonate 5-lipoxygenase purified from porcine leukocytes--5S-oxygenase, leukotriene A synthase and 6R-oxygenase activities. Ueda N; Yamamoto S Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():74-7. PubMed ID: 2526565 [No Abstract] [Full Text] [Related]